Proteinases involved in matrix turnover during cartilage and bone breakdown

Cell and Tissue Research

Volumn 339, Issue 1, 2010, Pages 221-235

  Cawston, Tim E ^a   Young, David A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Arthritis; Cartilage; Collagen; Extracellular matrix; Metalloproteinase

Indexed keywords

ADENOVIRUS VECTOR; AGGRECANASE; ALPHA 2 MACROGLOBULIN; ASPARTIC PROTEINASE; CATHEPSIN K; CIPEMASTAT; CYSTEINE PROTEINASE; DOXYCYCLINE; DOXYCYCLINE HYCLATE; ELASTASE; GELATINASE A; GELATINASE B; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 17; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 17; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; N1 [2,2 DIMETHYL 1 [(METHYLAMINO)CARBONYL]PROPYL] N4 HYDROXY 2 (2 METHYLPROPYL)BUTANEDIAMIDE; PROTEINASE; SERINE PROTEINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TANOMASTAT; THREONINE PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ACETYLATION; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CARTILAGE DEGENERATION; CLINICAL TRIAL; DRUG WITHDRAWAL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY DISEASE; JOINT DESTRUCTION; MUSCULOSKELETAL DISEASE; NONHUMAN; OSTEOARTHRITIS; OSTEOCLAST; OSTEOLYSIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ANIMALS; BONE AND BONES; CARTILAGE; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; JOINTS; METALLOPROTEASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 72449205067     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-009-0887-6     Document Type: Review

References (163)

1. D Ahrens AE Koch RM Pope M Stein-Picarella MJ Niedbala 1996 Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis Arthritis Rheum 39 1576 1587 1:STN:280:DyaK28vgvFSrtQ%3D%3D 8814070
2. RT Aimes JP Quigley 1995 Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4 and 1/4-length fragments J Biol Chem 270 5872 5876 1:CAS:528:DyaK2MXksVCntrk%3D 7890717
3. EC Arner CE Hughes CP Decicco B Caterson MD Tortorella 1998 Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase Osteoarthritis Cartilage 6 214 228 1:STN:280:DyaK1czkslOisg%3D%3D 9682788
4. Barrett AJ, Rawlings ND, Woessner JF Jr (1998) Handbook of proteolytic enzymes. Academic Press, New York
5. JD Becherer CP Blobel 2003 Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs) Curr Top Dev Biol 54 101 123 1:CAS:528:DC%2BD3sXjslygtbs%3D 12696747
6. WB van den Berg 1999 The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis Z Rheumatol 58 136 141 10441840
7. WB van den Berg 2000 Pathophysiology of osteoarthritis Joint Bone Spine 67 555 556 11195322
8. CJ Billington IM Clark TE Cawston 1998 An aggrecan-degrading activity associated with chondrocyte membranes Biochem J 336 207 212 1:CAS:528: DyaK1cXotVGltLk%3D 9806902
9. RA Black CT Rauch CJ Kozlosky JJ Peschon JL Slack MF Wolfson BJ Castner KL Stocking 1997 A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells Nature 385 729 733 1:CAS:528:DyaK2sXhsVGktLs%3D 9034190
10. F Blanchard C Chipoy 2005 Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today 10 197 204 1:CAS:528:DC%2BD2MXhtlajsbY%3D 15708534
11. HB Boldt MT Overgaard LS Laursen K Weyer L Sottrup-Jensen C Oxvig 2001 Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin Biochem J 358 359 367 1:CAS:528:DC%2BD3MXmvFWntrc%3D 11513734
12. N Borkakoti 2004 Matrix metalloprotease inhibitors: design from structure Biochem Soc Trans 32 17 20 1:CAS:528:DC%2BD2cXisVGrtr4%3D 14748704
13. MJ Bossard TA Tomaszek SK Thompson BY Amegadzie CR Hanning C Jones JT Kurdyla DE McNulty FH Drake M Gowen MA Levy 1996 Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification J Biol Chem 271 12517 12524 1:CAS:528:DyaK28XjtFantrc%3D 8647860
14. K Brew D Dinakarpandian H Nagase 2000 Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 267 283 1:CAS:528:DC%2BD3cXhsFGktbs%3D 10708863
15. E de Bri W Lei O Svensson M Chowdhury SA Moak RA Greenwald 1998 Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs Adv Dent Res 12 82 85 9972127
16. H Bryson RAD Bunning R Feltell CM Kam J Kerrigan JC Powers DJ Buttle 1998 A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines Arch Biochem Biophys 355 15 25 1:CAS:528:DyaK1cXks1egsLk%3D 9647662
17. MC Burleigh AJ Barrett GS Lazarus 1974 Cathepsin B1. A lysosomal enzyme that degrades native collagen Biochem J 137 387 398 1:CAS:528:DyaE2cXktVSktbw%3D 4207388
18. GS Butler H Will SJ Atkinson G Murphy 1997 Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases Eur J Biochem 244 653 657 1:CAS:528:DyaK2sXhvVKks7k%3D 9119036
19. DJ Buttle H Bramwell AP Hollander 1995 Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy? Clin Pathol Mol Pathol 48 M167 M177 1:CAS:528:DyaK2MXpsl2nurc%3D
20. IK Campbell J Wojta U Novak JA Hamilton 1994 Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor α and up-regulation by transforming growth factor-β and basic fibroblast growth factor Biochim Biophys Acta 1226 277 285 1:CAS:528:DyaK2cXltlajs70%3D 8054359
21. B Caterson CR Flannery CE Hughes CB Little 2000 Mechanisms involved in cartilage proteoglycan catabolism Matrix Biol 19 333 344 1:CAS:528: DC%2BD3cXmsVKlsbc%3D 10963994
22. TE Cawston 1996 Metalloproteinases inhibitors and the prevention of connective tissue breakdown Pharmacol Ther 70 163 182 1:CAS:528: DyaK28XkvVKqtrY%3D 8888065
23. TE Cawston VA Curry CA Summers IM Clark GP Riley PF Life JR Spaull MB Goldring PJ Koshy AD Rowan WD Shingleton 1998 The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint Arthritis Rheum 41 1760 1771 1:CAS:528:DyaK1cXmvFWmsLg%3D 9778217
24. T Chau G Jolly MJ Plym M McHugh E Bortolon J Wakefield C Gianpaolo-Ostravage C Maniglia 1998 Inhibition of articular cartilage degradation in dog and guinea-pig models of osteoarthritis by the stromelysin inhibitor, BAY-12-9566 Arthritis Rheum 41 S300
25. A Chevrier JS Mort P Crine CD Hoemann MD Buschmann 2001 Soluble recombinant neprilysin induces aggrecanase-mediated cleavage of aggrecan in cartilage explant cultures Arch Biochem Biophys 396 178 186 1:CAS:528: DC%2BD3MXptFWrsLo%3D 11747295
26. QY Choo PC Ho HS Lin 2008 Histone deacetylase inhibitors: new hope for rheumatoid arthritis? Curr Pharm Des 14 803 820 1:CAS:528:DC%2BD1cXlsVOjsr0%3D 18393882
27. YL Chung MY Lee AJ Wang LF Yao 2003 A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis Mol Ther 8 707 717 1:CAS:528: DC%2BD3sXos1Chu7o%3D 14599803
28. IM Clark AE Parker 2003 Metalloproteinases: their role in arthritis and potential as therapeutic targets Expert Opin Ther Targets 7 19 34 1:CAS:528:DC%2BD3sXhsV2ltb4%3D 12556200
29. IM Clark TE Swingler CL Sampieri DR Edwards 2008 The regulation of matrix metalloproteinases and their inhibitors Int J Biochem Cell Biol 40 1362 1378 1:CAS:528:DC%2BD1cXlslGlu7o%3D 18258475
30. SB Cohen TT Cheng V Chindalore N Damjanov R Burgos-Vargas P Delora K Zimany H Travers JP Caulfield 2009 Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate- controlled study of patients with active rheumatoid arthritis Arthritis Rheum 60 335 344 1:CAS:528:DC%2BD1MXjt1CgtL4%3D 19180516
31. LA Collins-Racie CR Flannery W Zeng C Corcoran B Annis-Freeman MJ Agostino M Arai E DiBlasio-Smith AJ Dorner KE Georgiadis M Jin XY Tan EA Morris ER LaVallie 2004 ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage Matrix Biol 23 219 230 1:CAS:528:DC%2BD2cXmsVGntrY%3D 15296936
32. JM Delaisse Y Eeckhout G Vaes 1980 Inhibition of bone resorption in culture by inhibitors of thiol proteinases Biochem J 192 365 368 1:CAS:528:DyaL3MXnslKitQ%3D%3D 6272702
33. JM Delaisse Y Eeckhout G Vaes 1984 In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption Biochem Biophys Res Commun 125 441 447 1:CAS:528:DyaL2MXmtVSjtA%3D%3D 6393977
34. J Dudler N Renggli-Zulliger N Busso M Lotz A So 2000 Effect of interleukin 17 on proteoglycan degradation in murine knee joints Ann Rheum Dis 59 529 532 1:CAS:528:DC%2BD3cXlsF2hs78%3D 10873962
35. Y Eeckhout G Vaes 1977 Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysomal cathepsin B, plasmin and kallikrein and spontaneous activation Biochem J 166 21 31 1:CAS:528:DyaE2sXlsVOktL8%3D 197917
36. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174 1:CAS:528:DC%2BD38Xis1KktL8%3D 11990853
37. AJ Ellis VA Curry EK Powell TE Cawston 1994 The prevention of collagen breakdown in bovine nasal cartilage by TIMP-1, TIMP-2 and a low molecular weight synthetic inhibitor Biochem Biophys Res Commun 201 94 101 1:CAS:528: DyaK2cXkvF2gsr0%3D 8198615
38. DJ Etherington 1972 The nature of the collagenolytic cathepsin of rat liver and its distribution in other rat tissues Biochem J 127 685 692 1:CAS:528:DyaE38XksFyhtbc%3D 4651135
39. V Everts W Beertsen W Tigchelaar-Gutter 1985 The digestion of phagocytosed collagen is inhibited by the proteinase inhibitors leupeptin and E-64 Collagen Relat Res 5 315 336 1:CAS:528:DyaL2MXlslKru7s%3D
40. V Everts JM Delaisse W Korper A Niehof G Vaes W Beertsen 1992 Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases J Cell Physiol 150 221 231 1:CAS:528:DyaK38XhtVegu7w%3D 1734028
41. V Everts E Van der Zee L Creemers W Beertsen 1996 Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling Histochem J 28 229 245 1:CAS:528:DyaK28XktlaktLk%3D 8762055
42. DT Felson LS Lohmander 2009 Whither osteoarthritis biomarkers? Osteoarthritis Cartilage 17 419 422 1:STN:280:DC%2BD1M3gsVSnsg%3D%3D 19248750
43. GS Firestein 2003 Evolving concepts of rheumatoid arthritis Nature 423 356 361 1:CAS:528:DC%2BD3sXjs1ynu7c%3D 12748655
44. AJ Fosang PJ Neame K Last TE Hardingham G Murphy JA Hamilton 1992 The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B J Biol Chem 267 19470 19474 1:CAS:528:DyaK38Xlt1KktL4%3D 1326552
45. SS Glasson R Askew B Sheppard B Carito T Blanchet HL Ma CR Flannery D Peluso K Kanki Z Yang MK Majumdar EA Morris 2005 Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis Nature 434 644 648 1:CAS:528:DC%2BD2MXislCmsr8%3D 15800624
46. MB Goldring 2000 The role of the chondrocyte in osteoarthritis Arthritis Rheum 43 1916 1926 1:STN:280:DC%2BD3cvmt1aqsg%3D%3D 11014341
47. MB Goldring M Otero K Tsuchimochi K Ijiri Y Li 2008 Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism Ann Rheum Dis 67 Suppl 3 iii75 iii82 1:CAS:528:DC%2BD1MXjt1OlsA%3D%3D 19022820
48. J Greene M Wang YE Liu LA Raymond C Rosen YE Shi 1996 Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 J Biol Chem 271 30375 30380 1:CAS:528:DyaK28XntlamsLo%3D 8939999
49. BL Gruber D Sorbi DL French MJ Marchese GJ Nuovo RR Kew LA Arbeit 1996 Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potential useful laboratory marker Clin Immunol Immunopathol 78 161 171 1:STN:280:DyaK287psFWmuw%3D%3D 8625558
50. H Guo R Li S Zucker BP Toole 2000 EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface Cancer Res 60 888 891 1:CAS:528:DC%2BD3cXhs1Shsr8%3D 10706100
51. MA Halili MR Andrews MJ Sweet DP Fairlie 2009 Histone deacetylase inhibitors in inflammatory disease Curr Top Med Chem 9 309 319 1:CAS:528:DC%2BD1MXntVCitrk%3D 19355993
52. Z Han DL Boyle L Chang B Bennett M Karin L Yang AM Manning GS Firestein 2001 c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis J Clin Invest 108 73 81 1:CAS:528:DC%2BD3MXkvVars7s%3D 11435459
53. C He SM Wilhelm AP Pentland BL Marmer GA Grant AZ Eisen GI Goldberg 1989 Tissue cooperation in a proteolytic cascade activating human interstitial collagenase Proc Natl Acad Sci USA 86 2632 2636 1:CAS:528:DyaL1MXit12jt70%3D 2468156
54. RM Hembry MR Bagga JJ Reynolds DL Hamblen 1995 Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis Ann Rheum Dis 54 25 32 1:STN:280:DyaK2M7osFygug%3D%3D 7880117
55. FJ Hemmings M Farhan J Rowland L Banken R Jain 2001 Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis Rheumatology (Oxford) 40 537 543 1:CAS:528: DC%2BD3MXkvFymurk%3D
56. WS Hou Z Li RE Gordon K Chan MJ Klein R Levy M Keysser G Keyszer D Bromme 2001 Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation Am J Pathol 159 2167 2177 1:CAS:528:DC%2BD38XhslaqtQ%3D%3D 11733367
57. WS Hou W Li G Keyszer E Weber R Levy MJ Klein EM Gravallese SR Goldring D Bromme 2002 Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium Arthritis Rheum 46 663 674 1:CAS:528: DC%2BD38XisFOmt7g%3D 11920402
58. W Hui HE Barksby DA Young TE Cawston N McKie AD Rowan 2005 Oncostatin M in combination with tumour necrosis factor alpha induces a chondrocyte membrane-associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2 Ann Rheum Dis 64 1624 1632 1:CAS:528:DC%2BD2MXht1eksrjJ 15883123
59. KM Hummel PK Petrow JK Franz U Muller-Ladner WK Aicher RE Gay D Bromme S Gay 1998 Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction J Rheumatol 25 1887 1894 1:CAS:528:DyaK1cXmvVentL8%3D 9779840
60. T Inaoka G Bilbe O Ishibashi K Tezuka M Kumegawa T Kokubo 1995 Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone Biochem Biophys Res Commun 206 89 96 1:CAS:528: DyaK2MXjtVWmur4%3D 7818555
61. RV Iozzo 1998 Matrix proteoglycans: from molecular design to cellular function Annu Rev Biochem 67 609 652 1:CAS:528:DyaK1cXlsFOmsbo%3D 9759499
62. H Ishikawa Y Nakagawa K Shimizu H Nishihara Y Matsusue T Nakamura 1999 Inflammatory cytokines induced down-regulation of m-calpain mRNA expression in fibroblastic synoviocytes from patients with osteoarthritis and rheumatoid arthritis Biochem Biophys Res Commun 266 341 346 1:CAS:528:DyaK1MXnvFersrY%3D 10600505
63. T Ishikawa F Nishigaki S Miyata Y Hirayama K Minoura J Imanishi M Neya T Mizutani Y Imamura Y Naritomi H Murai Y Ohkubo A Kagayama S Mutoh 2005 Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031 Br J Pharmacol 144 133 143 1:CAS:528:DC%2BD2MXitVeksQ%3D%3D 15644877 (Pubitemid 40188555)
64. T Ishikawa F Nishigaki S Miyata Y Hirayama K Minoura J Imanishi M Neya T Mizutani Y Imamura Y Ohkubo S Mutoh 2005 Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840 Eur J Pharmacol 508 239 247 1:CAS:528:DC%2BD2MXmvFyrtQ%3D%3D 15680277 (Pubitemid 40169925)
65. RW Johnstone 2002 Histone-deacetylase inhibitors: novel drugs for the treatment of cancer Nat Rev Drug Discov 1 287 299 1:CAS:528:DC%2BD38XivVGmsb0%3D 12120280
66. W Kafienah D Bromme DJ Buttle LJ Croucher AP Hollander 1998 Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix Biochem J 331 727 732 1:CAS:528:DyaK1cXjt12iu7s%3D 9560298
67. M Kashiwagi M Tortorella H Nagase K Brew 2001 TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5) J Biol Chem 276 12501 12504 1:CAS:528:DC%2BD3MXjtFyntr0%3D 11278243
68. L Kevorkian DA Young C Darrah ST Donell L Shepstone S Porter SM Brockbank DR Edwards AE Parker IM Clark 2004 Expression profiling of metalloproteinases and their inhibitors in cartilage Arthritis Rheum 50 131 141 1:CAS:528:DC%2BD2cXht1Kru7w%3D 14730609
69. DE Kleiner Jr WG Stetler-Stevenson 1993 Structural biochemistry and activation of matrix metalloproteases Curr Opin Cell Biol 5 891 897 1:CAS:528:DyaK3sXmsVCjsr0%3D 8240832
70. V Knäuper SM Wilhelm PK Seperack YA DeClerck KE Langley A Osthues H Tschesche 1993 Direct activation of human neutrophil procollagenase by recombinant stromelysin Biochem J 295 581 586 8240261
71. V Knäuper C López-Otin B Smith G Knight G Murphy 1996 Biochemical characterization of human collagenase-3 J Biol Chem 271 1544 1550 8576151
72. V Knäuper H Will C López-Otin B Smith SJ Atkinson H Stanton RM Hembry G Murphy 1996 Cellular mechanisms for human procollagenase-3 (MMP-13) activation J Biol Chem 271 17124 17131 8663255
73. YT Konttinen M Ainola H Valleala J Ma H Ida J Mandelin RW Kinne S Santavirta T Sorsa C López-Otin M Takagi 1999 Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis Ann Rheum Dis 58 691 697 1:CAS:528:DyaK1MXotV2itr0%3D 10531073
74. PJ Koshy N Henderson C Logan PF Life TE Cawston AD Rowan 2002 Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines Ann Rheum Dis 61 704 713 1:CAS:528:DC%2BD38XmsVajur4%3D 12117676
75. PJ Koshy CJ Lundy AD Rowan S Porter DR Edwards A Hogan IM Clark TE Cawston 2002 The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction Arthritis Rheum 46 961 967 1:CAS:528:DC%2BD38Xjs12lt7k%3D 11953973
76. T Kouzarides 2000 Acetylation: a regulatory modification to rival phosphorylation? EMBO J 19 1176 1179 1:CAS:528:DC%2BD3cXit1Gms7o%3D 10716917
77. W van der Laan E Molenaar K Ronday J Verheijen F Breedveld R Greenwald B Dijkmans J TeKoppele 2001 Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial J Rheumatol 28 1967 1974 11550961
78. WH van der Laan PH Quax CA Seemayer LG Huisman EJ Pieterman JM Grimbergen JH Verheijen FC Breedveld RE Gay S Gay TW Huizinga T Pap 2003 Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3 Gene Ther 10 234 242 12571631
79. MH Lee M Rapti V Knauper G Murphy 2004 Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition J Biol Chem 279 17562 17569 1:CAS:528:DC%2BD2cXjt1GntL0%3D 14734567
80. MH Lee M Rapti G Murphy 2005 Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of TNF-a converting enzyme (TACE) J Biol Chem 280 15967 15975 1:CAS:528:DC%2BD2MXjtleitrw%3D 15713681
81. RL Leff I Elias M Ionescu A Reiner AR Poole 2003 Molecular changes in human osteoarthritic cartilage after 3 weeks of oral administration of BAY 12-9566, a matrix metalloproteinase inhibitor J Rheumatol 30 544 549 1:CAS:528:DC%2BD3sXisVKgsrY%3D 12610815
82. EJ Lewis J Bishop KM Bottomley D Bradshaw M Brewster MJ Broadhurst PA Brown JM Budd L Elliott AK Greenham WH Johnson JS Nixon F Rose B Sutton K Wilson 1997 Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo Br J Pharmacol 121 540 546 1:CAS:528: DyaK2sXjs1Klsbk%3D 9179398
83. Z Li WS Hou D Bromme 2000 Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates Biochemistry 39 529 536 1:CAS:528:DyaK1MXotFKgt70%3D 10642177
84. LJ MacPherson EK Bayburt MP Capparelli BJ Carroll R Goldstein MR Justice L Zhu S Hu RA Melton L Fryer RL Goldberg JR Doughty S Spirito V Blancuzzi D Wilson EM O'Byrne V Ganu DT Parker 1997 Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits J Med Chem 40 2525 2532 1:CAS:528:DyaK2sXlt1yntbY%3D 9258358
85. SA Mazzuca KD Brandt KA Lane BP Katz 2003 Subject retention and adherence to dosing regimen in a 30-month clinical trial of doxycycline (doxy) as a disease-modifying osteoarthritis drug (DMOARD) Arthritis Rheum 48 294
86. N McKie T Edwards DJ Dallas A Houghton B Stringer R Graham G Russell PI Croucher 1997 Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes Biochem Biophys Res Comm 230 335 339 1:CAS:528:DyaK2sXlsVaquw%3D%3D 9016778
87. S Medicherla JY Ma R Mangadu Y Jiang JJ Zhao R Almirez I Kerr EG Stebbins G O'Young AM Kapoun G Luedtke S Chakravarty S Dugar HK Genant AA Protter 2006 A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis J Pharmacol Exp Ther 318 132 141 1:CAS:528:DC%2BD28XmsFymsbo%3D 16597712
88. K Mihara C Almansa RL Smeets EE Loomans J Dulos PM Vink M Rooseboom H Kreutzer F Cavalcanti AM Boots RL Nelissen 2008 A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha Br J Pharmacol 154 153 164 1:CAS:528:DC%2BD1cXltFOru70%3D 18297096
89. JM Milner SF Elliott TE Cawston 2001 Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways Arthritis Rheum 44 2084 2096 1:CAS:528: DC%2BD3MXpt12ltrg%3D 11592371
90. JM Milner AD Rowan SF Elliott TE Cawston 2003 Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation Arthritis Rheum 48 1057 1066 1:CAS:528:DC%2BD3sXjtlKns70%3D 12687549
91. JM Milner L Kevorkian DA Young D Jones R Wait ST Donell E Barksby AM Patterson J Middleton BF Cravatt IM Clark AD Rowan TE Cawston 2006 Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis Arthritis Res Ther 8 R23 16507127
92. JM Milner A Patel AD Rowan 2008 Emerging roles of serine proteinases in tissue turnover in arthritis Arthritis Rheum 58 3644 3656 1:CAS:528: DC%2BD1MXmt1yntA%3D%3D 19035508
93. 1-antitrypsin: a paradigm for other SERPINs Int J Biochem Cell Biol 29 1501 1511 1:CAS:528:DyaK1cXitlOls78%3D 9570144
94. TG Morgan AD Rowan SC Dickinson D Jones AP Hollander D Deehan TE Cawston 2006 Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases Ann Rheum Dis 65 184 190 1:CAS:528: DC%2BD28XhsFeitLw%3D 15975972
95. H Mori F Abe S Furukawa F Sakai M Hino T Fujii 2003 FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models J Antibiot (Tokyo) 56 80 86 1:CAS:528:DC%2BD3sXhvFenu7Y%3D (Pubitemid 36372788)
96. JS Mort CJ Billington 2001 Articular cartilage and changes in arthritis: matrix degradation Arthritis Res 3 337 341 1:CAS:528:DC%2BD38XjsVeguw%3D%3D 11714387
97. G Murphy MI Cockett PE Stephens B Smith AJP Docherty 1987 Stromelysin is an activator of procollagenase J Biochem 248 265 268 1:CAS:528: DyaL1cXhvVektg%3D%3D
98. G Murphy T Crabbe 1995 Gelatinases A and B Methods Enzymol 248 470 484 1:CAS:528:DyaK2MXptVShs7k%3D 7674939
99. H Nagase 1995 Stromelysins 1 and 2 Methods Enzymol 248 449 470 1:CAS:528:DyaK2MXptVShs7g%3D 7674937
100. H Nagase JF Woessner Jr 1999 Matrix metalloproteinases J Biol Chem 274 21491 21494 1:CAS:528:DyaK1MXltVynu7s%3D 10419448
101. H Nagase K Brew 2003 Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors Biochem Soc Symp 70 201 212 1:CAS:528:DC%2BD2cXktFensrs%3D 14587293
102. J Nemunaitis C Poole J Primrose A Rosemurgy J Malfetano P Brown A Berrington A Cornish K Lynch H Rasmussen D Kerr D Cox A Millar 1998 Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies Clin Cancer Res 4 1101 1109 1:CAS:528:DyaK1cXjt1yiurw%3D 9607566
103. K Nishida T Komiyama S Miyazawa ZN Shen T Furumatsu H Doi A Yoshida J Yamana M Yamamura Y Ninomiya H Inoue H Asahara 2004 Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression Arthritis Rheum 50 3365 3376 1:CAS:528:DC%2BD2cXpvFait74%3D 15476220
104. M Nishikawa A Myoui T Tomita K Takahi A Nampei H Yoshikawa 2003 Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653 Arthritis Rheum 48 2670 2681 1:CAS:528:DC%2BD3sXot1WjtL4%3D 13130488
105. O'Byrne EM, Blancuzzi V, Singh H, MacPherson LJ, Parker DT, Roberts ED (1999) Chondroprotective activity of a matrix metalloproteinase inhibitor, CGS 27023A in animal models of osteoarthritis. Springer, Tokyo
106. Y Ogata JJ Enghild H Nagase 1992 Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9 J Biol Chem 267 3581 3584 1:CAS:528:DyaK38XhvFSjtr0%3D 1371271
107. E Ohuchi K Imai Y Fujii H Satio M Seiki Y Okada 1997 Membrane type 1 matrix metalloproteinase digests interstitial collagenase and other extracellular macromolecules J Biol Chem 272 2446 2451 1:CAS:528: DyaK2sXotFeguw%3D%3D 8999957
108. Y Okada M Shinmei O Tanaka K Naka A Kimura I Nakanishi MT Bayliss K Iwata H Nagase 1992 Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium Lab Invest 66 680 690 1:STN:280: DyaK383pt1Ggsg%3D%3D 1602738
109. MT Overgaard HB Boldt LS Laursen L Sottrup-Jensen CA Conover C Oxvig 2001 Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase J Biol Chem 276 21849 21853 1:CAS:528:DC%2BD3MXksFGksbw%3D 11264294
110. M Pavlaki S Zucker 2003 Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials Cancer Metastasis Rev 22 177 203 1:CAS:528:DC%2BD3sXis1CjtL4%3D 12784996
111. D Pei 1999 Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP J Biol Chem 274 8925 8932 1:CAS:528: DyaK1MXitFyrtbo%3D 10085137
112. S Porter IM Clark L Kevorkian DR Edwards 2005 The ADAMTS metalloproteinases Biochem J 386 15 27 1:CAS:528:DC%2BD2MXhtFWmsbk%3D 15554875
113. AJ Powell CB Little CE Hughes 2007 Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system Arthritis Rheum 56 3010 3019 1:CAS:528:DC%2BD2sXht1Ggtb3P 17763444
114. P Primakoff DG Myles 2000 The ADAM gene family: surface proteins with adhesion and protease activity Trends Genet 16 83 87 1:CAS:528: DC%2BD3cXpsFGqtA%3D%3D 10652535
115. JC Rodriguez-Manzaneque J Westling SN Thai A Luque V Knauper G Murphy JD Sandy ML Iruela-Arispe 2002 ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors Biochem Biophys Res Commun 293 501 508 1:CAS:528:DC%2BD38XksVGhsrk%3D 12054629
116. FM Rogerson H Stanton CJ East SB Golub L Tutolo PJ Farmer AJ Fosang 2008 Evidence of a novel aggrecan-degrading activity in cartilage: studies of mice deficient in both ADAMTS-4 and ADAMTS-5 Arthritis Rheum 58 1664 1673 1:CAS:528:DC%2BD1cXotVOntro%3D 18512787
117. HK Ronday WH van der Laan PP Tak JA de Roos RA Bank JM TeKoppele CJ Froelich CE Hack PC Hogendoorn FC Breedveld JH Verheijen 2001 Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis Rheumatology (Oxford) 40 55 61 1:CAS:528:DC%2BD3MXhtlKht7g%3D
118. AD Rowan W Hui TE Cawston CD Richards 2003 Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model Am J Pathol 162 1975 1984 1:CAS:528:DC%2BD3sXkvVyjt74%3D 12759253
119. MD Roycik X Fang QX Sang 2009 A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates Curr Pharm Des 15 1295 1308 1:CAS:528:DC%2BD1MXmtValtr4%3D 19355969
120. ME Ryan RA Greenwald LM Golub 1996 Potential of tetracyclines to modify cartilage breakdown in osteoarthritis Curr Opin Rheumatol 8 238 247 1:CAS:528:DyaK2sXktlSgtL0%3D 8796985
121. M Sabatini C Lesur M Thomas A Chomel P Anract G de Nanteuil P Pastoureau 2005 Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis Arthritis Rheum 52 171 180 1:CAS:528:DC%2BD2MXht1Kitrw%3D 15641085
122. JD Sandy CR Flannery PJ Neame LS Lohmander 1992 The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond J Clin Invest 89 1512 1516 1:CAS:528:DyaK38Xkt1CiurY%3D 1569188
123. H Sato T Takino Y Okada J Cao A Shinagawa E Yamamoto M Seiki 1994 A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 61 65 1:CAS:528:DyaK2cXlvFOhtrs%3D 8015608
124. G Schett K Redlich S Hayer J Zwerina B Bolon C Dunstan B Gortz A Schulz H Bergmeister G Kollias G Steiner JS Smolen 2003 Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice Arthritis Rheum 48 2042 2051 1:CAS:528:DC%2BD3sXmtFartbY%3D 12847699
125. WD Shingleton AJ Ellis AD Rowan TE Cawston 2000 Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and - 13 are involved in cartilage collagen breakdown J Cell Biochem 79 519 531 1:CAS:528:DC%2BD3cXnslKhsrY%3D 10996843
126. T Shouda T Yoshida T Hanada T Wakioka M Oishi K Miyoshi S Komiya K Kosai Y Hanakawa K Hashimoto K Nagata A Yoshimura 2001 Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis J Clin Invest 108 1781 1788 1:CAS:528:DC%2BD3MXpt1Sjs7w%3D 11748261
127. M Skoumal G Haberhauer G Kolarz G Hawa W Woloszczuk A Klingler 2005 Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction Arthritis Res Ther 7 R65 R70 1:CAS:528:DC%2BD2cXhtVOjtLrF 15642144
128. RH Song MD Tortorella AM Malfait JT Alston Z Yang EC Arner DW Griggs 2007 Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5 Arthritis Rheum 56 575 585 1:CAS:528:DC%2BD2sXislShurw%3D 17265492
129. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation Proc Natl Acad Sci USA 87 364 368 1:CAS:528:DyaK3cXpsVCmuw%3D%3D 2153297
130. H Stanton L Ung AJ Fosang 2002 The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases Biochem J 364 181 190 1:CAS:528: DC%2BD38XktFWhsrs%3D 11988091
131. H Stanton FM Rogerson CJ East SB Golub KE Lawlor CT Meeker CB Little K Last PJ Farmer IK Campbell AM Fourie AJ Fosang 2005 ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro Nature 434 648 652 1:CAS:528:DC%2BD2MXislCmsrg%3D 15800625
132. MD Sternlicht Z Werb 2001 How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol 17 463 516 1:CAS:528:DC%2BD3MXos1Omsbs%3D 11687497
133. W Stocker F Grams U Baumann P Reinemer FX Gomis-Ruth DB McKay W Bode 1995 The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of
134. M Stone PR Fortin C Pacheco-Tena RD Inman 2003 Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity J Rheumatol 30 2112 2122 1:CAS:528:DC%2BD2cXltVegtw%3D%3D 14528503
135. K Suzuki K Shimizu T Hamamoto Y Nakagawa T Murachi T Yamamuro 1992 Characterization of proteoglycan degradation by calpain Biochem J 285 857 862 1:CAS:528:DyaK38XltVOjurc%3D 1497624
136. TE Swingler JG Waters RK Davidson CJ Pennington XS Puente C Darrah A Cooper ST Donell GR Guile W Wang IM Clark 2009 Degradome expression profiling in human articular cartilage Arthritis Res Ther 11 R96 19549314
137. Z Szomor K Shimizu Y Fujimori S Yamamoto T Yamamuro 1995 Appearance of calpain correlates with arthritis and cartilage destruction in collagen induced arthritic knee joints of mice Ann Rheum Dis 54 477 483 1:CAS:528: DyaK2MXmslOqtbg%3D 7632090
138. PP Tak DM Gerlag KR Aupperle DA van de Geest M Overbeek BL Bennett DL Boyle AM Manning GS Firestein 2001 Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation Arthritis Rheum 44 1897 1907 1:CAS:528:DC%2BD38XhtVSi 11508443
139. H Takaishi T Kimura S Dalal Y Okada J D'Armiento 2008 Joint diseases and matrix metalloproteinases: a role for MMP-13 Curr Pharm Biotechnol 9 47 54 1:CAS:528:DC%2BD1cXitVGjt7k%3D 18289056
140. T Takino H Sato A Shinagawa M Seiki 1995 Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library-MT-MMPs form a unique membrane-type subclass in the MMP family J Biol Chem 270 23013 23020 1:CAS:528:DyaK2MXosFyjsL8%3D 7559440
141. Tallant C, Marrero A, Gomis-Ruth FX (2009) Matrix metalloproteinases: fold and function of their catalytic domains. Biochim Biophys Acta (in press)
142. K Tanaka T Kawakami K Tateishi H Yashiroda T Chiba 2001 Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway Biochimie 83 351 356 1:CAS:528:DC%2BD3MXivFKgsr8%3D 11295496
143. LC Tetlow DJ Adlam DE Woolley 2001 Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage Arthritis Rheum 44 585 594 1:CAS:528:DC%2BD3MXislags70%3D 11263773
144. MD Tortorella AM Malfait C Deccico E Arner 2001 The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation Osteoarthritis Cartilage 9 539 552 1:STN:280:DC%2BD3MvnslGmug%3D%3D 11520168
145. MD Tortorella RQ Liu T Burn RC Newton E Arner 2002 Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4) Matrix Biol 21 499 511 1:CAS:528: DC%2BD38XotVCnurk%3D 12392761
146. V Turk B Turk D Turk 2001 Lysosomal cysteine proteases: facts and opportunities EMBO J 20 4629 4633 1:CAS:528:DC%2BD3MXnt1CmtrY%3D 11532926
147. HE Van Wart H Birkedal-Hansen 1990 The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family Proc Natl Acad Sci USA 87 5578 5582 2164689
148. J Varga J Rosenbloom SA Jimenez 1987 Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts Biochem J 247 597 604 1:CAS:528:DyaL2sXmtFGksLs%3D 3501287
149. G Velasco S Cal A Merlos-Suárez AA Ferrando S Alvarez A Nakano J Arribas C López-Otín 2000 Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors Cancer Res 60 877 882 1:CAS:528:DC%2BD3cXhs1Siu7c%3D 10706098
150. TH Vu Z Werb 2000 Matrix metalloproteinases: effectors of development and normal physiology Genes Dev 14 2123 2133 1:CAS:528:DC%2BD3cXmtlegu7o%3D 10970876
151. NC Walsh TN Crotti SR Goldring EM Gravallese 2005 Rheumatic diseases: the effects of inflammation on bone Immunol Rev 208 228 251 1:CAS:528: DC%2BD28Xks1ehsA%3D%3D 16313352
152. Z Werb CL Mainardi CA Vater ED Harris 1977 Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator N Engl J Med 296 1017 1023 1:CAS:528:DyaE2sXktVenurs%3D 66627
153. A Wlodawer 1995 Proteasome: a complex protease with a new fold and a distinct mechanism Structure 3 417 420 1:CAS:528:DyaK2MXlvFyhs7c%3D 7663937
154. GC Wolfe KL MacNaul FF Buechel J McDonnell LA Hoerrner MW Lark VL Moore NI Hutchinson 1993 Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis Arthritis Rheum 36 1540 1547 1:CAS:528:DyaK2cXisVWktb4%3D 8240430
155. Y Yamanishi DL Boyle M Clark RA Maki MD Tortorella EC Arner GS Firestein 2002 Expression and regulation of aggrecanase in arthritis: the role of TGF-beta J Immunol 168 1405 1412 1:CAS:528:DC%2BD38XpsFersw%3D%3D 11801682
156. Yamanouchi-Pharmaceutical (2001) Patent WO0134785
157. C Yan DD Boyd 2007 Regulation of matrix metalloproteinase gene expression J Cell Physiol 211 19 26 1:CAS:528:DC%2BD2sXis12jt70%3D 17167774
158. Y Yoshihara H Nakamura K Obata H Yamada T Hayakawa K Fujikawa Y Okada 2000 Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis Ann Rheum Dis 59 455 461 1:CAS:528:DC%2BD3cXksVCktbw%3D 10834863
159. DA Young RL Lakey CJ Pennington L Kevorkian DR Edwards TE Cawston IM Clark 2005 Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption Arthritis Res Ther 7 R503 R512 1:CAS:528:DC%2BD2MXivVygsLc%3D 15899037
160. WH Yu JF Woessner Jr 2000 Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7) J Biol Chem 275 4183 4191 1:CAS:528:DC%2BD3cXht12gt78%3D 10660581
161. W Zeng C Corcoran LA Collins-Racie ER Lavallie EA Morris CR Flannery 2006 Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18 Biochim Biophys Acta 1760 517 524 1:CAS:528:DC%2BD28Xis1egtrk%3D 16507336
162. Q Zhang W Hui GJ Litherland MJ Barter R Davidson C Darrah ST Donell IM Clark TE Cawston JH Robinson AD Rowan DA Young 2008 Differential Toll-like receptor-dependent collagenase expression in chondrocytes Ann Rheum Dis 67 1633 1641 1:CAS:528:DC%2BD1cXhtl2gsbfE 18258708
163. S Zucker D Pei J Cao C Lopez-Otin 2003 Membrane type-matrix metalloproteinases (MT-MMP) Curr Top Dev Biol 54 1 74 1:CAS:528: DC%2BD3sXjslygtb0%3D 12696745